Xilan Yang
Impact in
-
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Cardiac Valve Diseases and Treatments
-
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Tuberculosis Research and Epidemiology 1
- Viral Infections and Vectors 1
-
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Jian Jia (5 shared papers)Xiaoyu Luo (2 shared papers)Chen Qu (3 shared papers)Xueling Fan (1 shared paper)Sen Chen (1 shared paper)Yiyang Zhan (1 shared paper)N. A. Hill (1 shared paper)Ying Xu (3 shared papers)
- Journals
- APOPTOSIS (2 papers)Scientific Reports (1 paper)GigaScience (1 paper)Pulmonary Pharmacology & Therapeutics (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- ChinaUnited KingdomGermany
In The Last Decade
Xilan Yang
20 papers receiving 268 citations
Peers
Comparison fields: 5 of 78
- Cardiology and Cardiovascular Medicine 63
- Nephrology 19
- Biological Psychiatry 5
- Immunology 35
- Surgery 52
Countries citing papers authored by Xilan Yang
This map shows the geographic impact of Xilan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilan Yang more than expected).
Fields of papers citing papers by Xilan Yang
This network shows the impact of papers produced by Xilan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilan Yang. The network helps show where Xilan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xilan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 63 | |
| 2 | 2018 | 53 | |
| 3 | 2019 | 31 | |
| 4 | 2019 | 28 | |
| 5 | 2020 | 18 | |
| 6 | 2022 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2017 | 8 | |
| 10 | A modified "double-hit" induced acute lung injury model in rats and protective effects of tetramethylpyrazine on the injury via Rho/ROCK pathway. | 2015 | 7 |
| 11 | 2023 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2017 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Xilan Yang
Xilan Yang is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 21 papers that have together received 273 indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (3 papers), Cardiac Imaging and Diagnostics (3 papers), Cardiovascular Function and Risk Factors (2 papers), Inflammasome and immune disorders (2 papers), Genomics and Phylogenetic Studies (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Tuberculosis Research and Epidemiology (1 paper) and Viral Infections and Vectors (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (63 citations), Nephrology (19 citations), Biological Psychiatry (5 citations), Immunology (35 citations) and Surgery (52 citations). Xilan Yang has collaborated with scholars based in China, United Kingdom and Germany. Frequent co-authors include Jian Jia, Xiaoyu Luo, Chen Qu, Xueling Fan, Sen Chen, Yiyang Zhan, N. A. Hill, Ying Xu, Hao Gao and Weiwei Chen. Their work appears in journals such as APOPTOSIS, Scientific Reports, GigaScience, Pulmonary Pharmacology & Therapeutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.